A detailed history of Consolidated Planning Corp transactions in Johnson & Johnson stock. As of the latest transaction made, Consolidated Planning Corp holds 6,096 shares of JNJ stock, worth $947,318. This represents 0.16% of its overall portfolio holdings.

Number of Shares
6,096
Previous 6,110 0.23%
Holding current value
$947,318
Previous $893,000 10.53%
% of portfolio
0.16%
Previous 0.16%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 31, 2024

SELL
$145.48 - $167.38 $2,036 - $2,343
-14 Reduced 0.23%
6,096 $987,000
Q2 2024

Aug 02, 2024

SELL
$144.38 - $157.78 $3.38 Million - $3.69 Million
-23,392 Reduced 79.29%
6,110 $893,000
Q1 2024

May 02, 2024

BUY
$155.22 - $162.74 $66,744 - $69,978
430 Added 1.48%
29,502 $4.67 Million
Q4 2023

Feb 02, 2024

SELL
$145.6 - $158.88 $154,772 - $168,889
-1,063 Reduced 3.53%
29,072 $4.56 Million
Q3 2023

Nov 08, 2023

SELL
$155.75 - $174.48 $31,773 - $35,593
-204 Reduced 0.67%
30,135 $4.69 Million
Q2 2023

Aug 14, 2023

BUY
$154.35 - $166.11 $810,028 - $871,745
5,248 Added 20.92%
30,339 $5.02 Million
Q1 2023

May 04, 2023

BUY
$151.05 - $180.26 $902,674 - $1.08 Million
5,976 Added 31.26%
25,091 $3.89 Million
Q4 2022

Feb 10, 2023

BUY
$160.2 - $179.79 $2.41 Million - $2.71 Million
15,048 Added 370.0%
19,115 $3.38 Million
Q3 2022

Nov 04, 2022

SELL
$161.33 - $179.52 $34,524 - $38,417
-214 Reduced 5.0%
4,067 $664,000
Q2 2022

Aug 12, 2022

BUY
$168.19 - $186.01 $35,488 - $39,248
211 Added 5.18%
4,281 $760,000
Q1 2022

May 03, 2022

SELL
$158.14 - $179.59 $13,600 - $15,444
-86 Reduced 2.07%
4,070 $721,000
Q4 2021

Feb 11, 2022

SELL
$155.93 - $173.01 $12,474 - $13,840
-80 Reduced 1.89%
4,156 $711,000
Q3 2021

Nov 17, 2021

BUY
$161.5 - $179.47 $13,404 - $14,896
83 Added 2.0%
4,236 $684,000
Q2 2021

Jul 26, 2021

SELL
$159.48 - $171.07 $12,758 - $13,685
-80 Reduced 1.89%
4,153 $684,000
Q1 2021

May 05, 2021

BUY
$153.07 - $170.48 $34,134 - $38,017
223 Added 5.56%
4,233 $695,000
Q4 2020

Feb 05, 2021

BUY
$137.11 - $157.38 $21,663 - $24,866
158 Added 4.1%
4,010 $631,000
Q3 2020

Nov 10, 2020

SELL
$140.38 - $153.83 $7,580 - $8,306
-54 Reduced 1.38%
3,852 $573,000
Q2 2020

Aug 10, 2020

BUY
$128.81 - $155.51 $257 - $311
2 Added 0.05%
3,906 $549,000
Q1 2020

May 12, 2020

BUY
$111.14 - $153.99 $111 - $153
1 Added 0.03%
3,904 $512,000
Q4 2019

Apr 29, 2020

BUY
$127.5 - $146.44 $497,632 - $571,555
3,903 New
3,903 $569,000

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $406B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Consolidated Planning Corp Portfolio

Follow Consolidated Planning Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Consolidated Planning Corp, based on Form 13F filings with the SEC.

News

Stay updated on Consolidated Planning Corp with notifications on news.